Iron Acquisition and Siderophore Release by Carbapenem-Resistant Sequence Type 258 Klebsiella pneumoniae

Victoria I Holden1, Meredith S Wright2, Sébastien Houle3

  • 1Department of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, USA.

Msphere
|April 20, 2018
PubMed

Insights

Carbapenem-resistant Klebsiella pneumoniae strains, even those with a partial entS gene deletion, can acquire iron through enterobactin secretion and hemin utilization. This adaptability is crucial for their survival and infection despite antibiotic resistance.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Genomics

Background:

  • Klebsiella pneumoniae is a major cause of healthcare-associated infections, rapidly developing resistance to carbapenems.
  • Multilocus sequence type ST258 is the most prevalent carbapenem-resistant Enterobacteriaceae (CRE) globally.
  • A subset of ST258 strains possess a partial deletion in the enterobactin exporter gene entS, yet remain clinically significant.

Purpose of the Study:

  • To investigate the iron acquisition strategies of ST258 Klebsiella pneumoniae subtypes under iron-limited conditions.
  • To compare the transcriptional responses and siderophore production between ST258a and ST258b strains with and without the entS deletion.
  • To assess the impact of the entS deletion on bacterial growth and iron uptake mechanisms.

Main Methods:

  • Transcriptome sequencing (RNA-Seq) of ST258 strains in minimal medium with varying iron availability.
  • In vitro assays including Chrome Azurol S (CAS), Arnow assays, and mass spectrometry for siderophore production.
  • Growth curve analysis under iron-depleted conditions and hemin utilization assays.

Main Results:

  • Iron limitation induced distinct iron acquisition pathway expression in ST258a and ST258b strains.
  • Strains with partial entS deletions upregulated hemin transport operons.
  • Both ST258a and ST258b strains, irrespective of entS status, demonstrated growth in iron-depleted conditions, utilized hemin, and secreted enterobactin.
  • All tested carbapenem-resistant K. pneumoniae strains were susceptible to growth inhibition by lipocalin 2.

Conclusions:

  • Partial entS deletion does not abrogate enterobactin secretion or iron acquisition in carbapenem-resistant Klebsiella pneumoniae.
  • These adaptable strains can utilize alternative iron sources like hemin, contributing to their persistence.
  • Understanding these iron acquisition mechanisms is vital for developing novel therapeutic strategies against CRE infections.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
929
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
3.1K
Water and Mineral Acquisition02:34

Water and Mineral Acquisition

Specialized tissues in plant roots have evolved to capture water, minerals, and some ions from the soil. Roots exhibit a variety of branching patterns that facilitate this process. The outermost root cells have specialized structures called root hairs that increase the root surface, thus increasing soil contact. Water can passively cross into roots, as the concentration of water in the soil is higher than that of the root tissue. Minerals, in contrast, are actively transported into root cells.
35.9K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
830